Predictive value of magnetic resonance imaging signal and contrastenhancement characteristics on post-embolization volume reduction of uterine fibroids

Acta Radiologica

Volumn 47, Issue 4, 2006, Pages 427-435

  Harman, M ^a   Zeteroglu S ^a   Arslan, H ^a   Sengul M ^a   Etlik, O ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Embolization; Magnetic resonance imaging; Uterine fibroid

Indexed keywords

BIOMEDICAL ENGINEERING; DIAGNOSIS; GADOLINIUM; MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PATIENT TREATMENT;

CONTRAST-ENHANCEMENT FEATURES; EMBOLIZATION; UTERINE FIBROID; VOLUME REDUCTION;

MEDICAL IMAGING;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; POLYVINYL ALCOHOL;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; IMAGE ENHANCEMENT; LEIOMYOMA; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOLOGY; POSTOPERATIVE PERIOD; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; TREATMENT OUTCOME; UTERUS; UTERUS CANCER;

ADULT; CONTRAST MEDIA; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LEIOMYOMA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OBSERVER VARIATION; POLYVINYL ALCOHOL; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE NEOPLASMS; UTERUS;

EID: 33646415367     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850600557117     Document Type: Article

References (24)

1. Aziz A, Petrucco OSM, Makinoda S, Wikholm G, Svendsen P, Brannstrom M, et al. Transarterial embolization of the uterine arteries: patient reactions and effects on uterine vasculature. Acta Obstet Gynecol Scand 1998;77:334-40.
2. Banovac F, Ascher SM, Jones DA, Black MD, Smith JC, Spies JB. Magnetic resonance imaging outcome after uterine artery embolization for leiomyomata with use of tris-acryl gelatin microspheres. J Vase Interv Radiol 2002;13:681-8.
3. Broder MS, Goodwin S, Chen G, Tang LJ, Costantino MM, Nguyen MH, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol 2002; 100:864-8.
4. Burn PR, McCall JM, Chinn RJ, Vashisht A, Smith JR, Healy JC. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology 2000;214:729-34.
5. Burn P, McCall J, Chinn R, Healy J. Embolization of uterine fibroids. Br J Radiol 1999;72:159-61.
6. Dellacha A, Di Marco A, Fooglia G, Fulcheri E. Lipoleiomyoma of the uterus. Pathological 1997;89:737-41.
7. DeSouza NM, Williams AD. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome. Radiology 2002;222:367-74.
8. Fleischer AC, Donnelly EF, Campbell MG, Mazer MJ, Grippo D, Lipsitz NL. Three-dimensional color Doppler sonography before and after fibroid embolization. J Ultrasound Med 2000;19:701-5.
9. Jha RC, Ascher SM, Imaoka I, Spies JB. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology 2000;217:228-35.
10. Katsumori T, Nakajima K, Hanada Y. MR imaging of a uterine myoma after embolization. Am J Roentgenol 1999;172:248-9.
11. Katsumori T, Nakajima K, Tokuhiro M. Gadolinium-enhanced MR imaging in the evaluation of uterine fibroids treated with uterine artery embolization. Am J Roentgenol 2001;177:303-7.
12. Kawakami S, Togashi K, Konishi I, Kimura I, Fukuoka M, Mori T, et al. Red degeneration of uterine leiomyoma; MRI appearances. J Comput Assist Tomogr 1994;18:925-8.
13. McLucas B, Perrella R, Good win S, Adler L, Dalrymple J. Role of uterine artery Doppler flow in fibroid embolization. J Ultrasound Med 2002;21:113-20.
14. Oguchi O, Mori A, Kobayashi Y, Horiuchi A, Nikaido T, Fujii S. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J Obstet Gynecol 1995;21:107-17.
15. Omary R A, Vasireddy S, Chrisman HB, Ryu RK, Pereles FS, Carr JC, et al. The Effect of pelvic MR imaging on the diagnosis and treatment of women with presumed symptomatic uterine fibroids. J Vase Interv Radiol 2002;13:1149-53.
16. Ooto H, Nanbu Y, Nonogaki H. Treatment with LH RH analogue, Buserelin for uterine leiomyoma: assessment with MR imaging. Endometriosis Kenkyukai Kaishi 1989; 10:245-9.
17. Roth AR, Spies JB, Walsh SM, Wood BJ, Gomez-Jorge J, Levy EB. Pain after uterine artery embolization for leiomyomata: can its severity be predicted and does severity predict outcome? J Vase Interv Radiol 2000;11:1047-52.
18. Sampson J. The blood supply of uterine myomata. Surg Gynecol Obstet 1912;14:215.
19. Sasadeusz KJ, Andrews RT. Uterine fibroid embolization. Semin Roentgenol 2002;37:361-70.
20. Spies JB, Roth AR, Jha RC, Gomez-Jorge J, Levy EB, Chang TC, et al. Leiomyomata treated with uterine artery embolization: factors associated with successful symptom and imaging outcome. Radiology 2002;222: 45-52.
21. Sterling KM, Vogelzang RL, Chrisman HB, Worthington-Kirsch RL, Machan LS, Goodwin SC, et al. Uterine fibroid embolization: management of complications. Tech Vase Interv Radiol 2002;5:56-66.
22. Walker WJ, Pelage JP, Sutton C. Fibroid embolization. Clin Radiol 2002;57:325-31.
23. Watson CM, Walker WJ. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women's views of the success of the treatment. BJOG 2002; 109:129-35.
24. Yamashita Y, Torashima M, Takahashi M, Tanaka N, Katabuchi H, Miyazaki K, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology 1993; 189:721-5.